• 48 mg NaHA (2.0%) in 2.4 ml solution
• 1 injection
• Bacterial fermentation
• 3.0 M Da molecular weight
• 900,000 mPa.s viscosity

Reviscon Mono is an intra-articular injection with high molecular weight sodium hyaluronate to prevent pain and motion limitation for all joints caused by Osteoarthritis.

Reviscon Mono contains one of the highest molecular weight sodium hyaluronate with unique cohesive energy characteristics. Excellent rheological profile is designed for greater zero shear viscosity resulting in efficient pain relief and dynamic elasticity at higher shear rates for enduring mobility.